Media Center
Press Releases

Press Releases

16 May 17
First-in-class innovation a key strategy for pharmaceutical companies in a harsh market environment, says GBI Research

Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to reach market approval are factored in, according to business intelligence provider GBI Research.

Read post
11 May 17
Alzheimer’s disease space continues to see exceptionally high levels of first-in-class innovation, says GBI Research

The level of first-in-class innovation in the Alzheimer’s disease space is exceptionally high, with more than 65% of pipeline products with a disclosed molecular target identified as first-in-class, according to business intelligence provider GBI Research.

Read post
10 May 17
Global immunology market will surpass $75 billion by 2022 despite patent expirations

The global immunology market, which covers autoimmune diseases such as rheumatoid arthritis, psoriasis, lupus, and ankylosing spondylitis, is set to rise from $57.7 billion in 2015 to $75.4 billion by 2022, representing a compound annual growth rate of almost 4%, according to business intelligence provider GBI Research.

Read post
13 Apr 17
Southeast Asian breast cancer market to hit $2.7 billion by 2022 as prevalence rate rises, says GBI Research

The Southeast Asian breast cancer market, which covers South Korea, Singapore, Taiwan, Malaysia, the Philippines, Thailand, Vietnam and Indonesia, is set to rise from $942.3 million in 2015 to $2.7 billion in 2022, representing a compound annual growth rate of 16.2%, according to business intelligence provider GBI Research.

Read post
11 Apr 17
Rheumatoid arthritis market in Southeast Asia to reach $1.44 billion by 2022, says GBI Research

The rheumatoid arthritis market in Southeast Asia, which covers South Korea, Singapore, Taiwan, Malaysia, the Philippines, Thailand, Vietnam, and Indonesia, is set to grow from $1.04 billion in 2015 to $1.44 billion by 2022, representing a compound annual growth rate of 4.7%, according to business intelligence provider GBI Research.

Read post